Pharmajobs

• Combined addiction drugs help weight loss, report says
  
  30 Jul 2010
  US regulators assessing ‘Contrave’ license Read More
  
  

  Back to Top

• NICE issues new MND guidelines
  
  30 Jul 2010
  Standard of care and number of options set to increase Read More
  
  

  Back to Top

• Pfizer launches latest online service
  
  30 Jul 2010
  Surgery opened to avoid embarrassment Read More
  
  

  Back to Top

• French company acquires IMS Swiss business unit
  
  30 Jul 2010
  Cegedim expands service Read More
  
  

  Back to Top

• Government to remove default retirement age
  
  30 Jul 2010
  Government plans to remove the Default Retirement Age (DRA) by 2011 have met with a mixed reaction from employment and business organisations. Read More
  
  

  Back to Top

• Sanofi expected to bid for Genzyme
  
  30 Jul 2010
  Sanofi-aventis intends to make a formal offer of $18.7 billion for Genzyme, inside sources have revealed. Read More
  
  

  Back to Top

• Quintiles moves European HQ to Reading
  
  30 Jul 2010
  Pharmaceutical services company Quintiles is to re-locate its European headquarters to a state-of the-art facility in Reading. Read More
  
  

  Back to Top

• New capsule offers pharma ‘huge potential’
  
  29 Jul 2010
  DuoCap receives European patent Read More
  
  

  Back to Top

• Arixtra set for expanded license
  
  29 Jul 2010
  CHMP gives positive opinion for SVT treatment Read More
  
  

  Back to Top

• UKCMRI appoints Nobel Prize winner
  
  29 Jul 2010
  Sir Paul Nurse joins the collaboration Read More
  
  

  Back to Top

• US patients should get EMA-approved drugs, says report
  
  29 Jul 2010
  American patients should be allowed access to drugs approved by the European Medicines Agency (EMA), a new US report argues. Read More
  
  

  Back to Top

• Pfizer SlideShare channel criticised as ‘not social’
  
  29 Jul 2010
  Pfizer has launched its own social media channel, making it the first pharma company to do so. Read More
  
  

  Back to Top

• Servier accused of misleading EU authorities
  
  29 Jul 2010
  The European Commission has accused Servier of giving ‘incorrect and misleading’ information during the recent antitrust investigation into the pharmaceuticals sector. Read More
  
  

  Back to Top

• Movetis moves to the UK
  
  28 Jul 2010
  GI specialists establish new base Read More
  
  

  Back to Top

• Report shows rising cost of diabetes
  
  28 Jul 2010
  GPs called to follow NICE guidelines more closely Read More
  
  

  Back to Top

• New commissioning inquiry to be launched
  
  28 Jul 2010
  Latest review set for September into white paper reforms Read More
  
  

  Back to Top

• UK access to cancer drugs worst in Europe
  
  28 Jul 2010
  UK patients are not seeing the benefits of the country’s R&D efforts, says the ABPI. Read More
  
  

  Back to Top

• Amgen fails to provide Prolia data
  
  28 Jul 2010
  NICE has closed an appraisal of Amgen’s Prolia (denosumab) due to a lack of information about the drug’s cost effectiveness. Read More
  
  

  Back to Top

• MabThera gets NICE recommendation
  
  28 Jul 2010
  Treatment for chronic lymphocytic leukaemia now available Read More
  
  

  Back to Top

• NICE backs cancer treatments
  
  28 Jul 2010
  Treatments for inoperable advanced gastric cancer and for non-small-cell lung cancer recommended by NICE Read More
  
  

  Back to Top

• Cancer fund ‘could save hundreds of lives’
  
  27 Jul 2010
  An extra £50 million is to be made available to help patients access innovative new cancer drugs, the Government has revealed. Read More
  
  

  Back to Top

• NICE to review guidance on Vidaza for MDS
  
  27 Jul 2010
  NICE has promised to re-appraise the use of Vidaza (azacitidine) in patients with higher-risk myelodysplastic syndrome (MDS) – a group of debilitating bone marrow diseases. Read More
  
  

  Back to Top

• US GSK rep bonuses to be decided by customers
  
  27 Jul 2010
  Customer feedback will play a central role in deciding the bonuses that sales representatives working at GSK’s US subsidiary will receive, as part of a new scheme to be implemented from 2011 onwards. Read More
  
  

  Back to Top

• NHS bureaucracy making PASs unworkable
  
  27 Jul 2010
  Lengthy procedures costing Health Service Read More
  
  

  Back to Top

• EMA restricts use of modafinil
  
  27 Jul 2010
  Medicine to be used for narcolepsy only Read More
  
  

  Back to Top

• Companies hit by gender bias settlements
  
  27 Jul 2010
  Sanofi and Novartis ordered to change policies Read More
  
  

  Back to Top

• GPs not ready to deliver reforms
  
  26 Jul 2010
  The majority of GPs do not feel ready to deliver the new commissioning services as outlined Andrew Lansley’s white paper. Read More
  
  

  Back to Top

• Specialist teams set up for neglected cancer
  
  26 Jul 2010
  NICE guidelines could transform the treatment of patients whose cancer has spread from an unknown primary location. Read More
  
  

  Back to Top

• NICE approves more than 80% of treatments
  
  23 Jul 2010
  But ABPI challenges approval rate Read More
  
  

  Back to Top

• PCTs encouraged to offer consortia assistance
  
  23 Jul 2010
  The DH’s latest consultation paper – Liberating the NHS: commissioning for patients – says trusts must work closely with the new consortia to ensure “appropriate skills and knowledge are retained.” Read More
  
  

  Back to Top

• European pharma braced for prize squeeze
  
  23 Jul 2010
  European reduction in drug prices expected Read More
  
  

  Back to Top

• CHMP update
  
  23 Jul 2010
  July’s meeting of the CHMP saw just one new branded product recommended for a marketing authorisation, while three generic products secured positive opinions. Read More
  
  

  Back to Top

• Government reveals plans for local health services
  
  22 Jul 2010
  GP consortia will be in charge of commissioning health services at a local level, supported by an independent NHS commissioning board. Read More
  
  

  Back to Top

• UK HIV treatment adherence best in Europe
  
  22 Jul 2010
  UK HIV/AIDS patients have the highest rates of treatment adherence in Europe, yet a third still miss doses of medication. Read More
  
  

  Back to Top

• NHS sets aside £1.7 billion redundancy
  
  21 Jul 2010
  Critics against huge severance figures Read More
  
  

  Back to Top

• Emerging therapies set to double prostate cancer market by 2019
  
  21 Jul 2010
  New and emerging therapies set to expand the market Read More
  
  

  Back to Top

• Pfizer trial halted due to adverse events
  
  21 Jul 2010
  Pfizer has suspended clinical trials of its compound tanezumab in chronic lower back pain and painful diabetic peripheral neuropathy at the request of the FDA. Read More
  
  

  Back to Top

• ViiV hands HIV portfolio to generic firms
  
  21 Jul 2010
  ViiV Healthcare is to make all its patents available to generic companies to improve access to HIV medications in developing countries. Read More
  
  

  Back to Top

• GfK Healthcare to commence NICE study
  
  21 Jul 2010
  Study to access whether NICE is a suitable model for other markets to begin Read More
  
  

  Back to Top

• MRC funds new research project
  
  19 Jul 2010
  New research project set to assist NICE Read More
  
  

  Back to Top

• European Medicines Group elects new chair
  
  19 Jul 2010
  Matthew Speers takes over from Nigel Brooksby Read More
  
  

  Back to Top

• NICE issue guidance for dronedarone after positive comments
  
  16 Jul 2010
  NICE recommends dronedarone Read More
  
  

  Back to Top

• White Paper: ‘Compelling,’ but a ‘significant risk
  
  15 Jul 2010
  The Government’s White Paper for the NHS has been dismissed as a ‘political experiment’ that could destabilise the health service. Read More
  
  

  Back to Top

• Companies must adapt to new markets, says F&S
  
  14 Jul 2010
  Healthcare reform programmes in emerging markets have dramatically improved the level of healthcare coverage in these countries, new analysis from Frost & Sullivan has found. Read More
  
  

  Back to Top

• BCD M&I becomes ABPI affiliate
  
  14 Jul 2010
  BCD Meetings & Incentives has been approved by the Board of Management as a General Affiliate Member of the ABPI. Read More
  
  

  Back to Top

• Weak trial evidence fails Avastin
  
  13 Jul 2010
  NICE has decided not to recommend Roche’s Avastin (bevacizumab), in combination with a taxane, as a first-line treatment for metastatic breast cancer due to a lack of evidence in its favour. Read More
  
  

  Back to Top

• Reyataz is ‘milestone’ in children’s HIV treatment
  
  13 Jul 2010
  HIV treatment Reyataz (atazanavir sulfate) has been granted a paediatric indication in the EU. Read More
  
  

  Back to Top

• Steve Churton re-elected as RPSGB President
  
  12 Jul 2010
  Steve Churton has been re-elected as the President of the Royal Pharmaceutical Society of Great Britain. Read More
  
  

  Back to Top

• New President for the BMA
  
  12 Jul 2010
  Sir Michael Marmot will be setting out to tackle health inequalities over the next year in his role as the new President of the British Medical Association. Read More
  
  

  Back to Top

• Anger over NICE bone cancer drug guidance
  
  09 Jul 2010
  Patient groups have responded angrily to NICE’s decision not to back Takeda’s bone cancer treatment Mepact (mifamurtide). Read More
  
  

  Back to Top

• Novartis to compensate reps for unpaid overtime
  
  09 Jul 2010
  Novartis in the US will have to compensate its sales force following a court ruling that representatives qualify for overtime pay. Read More
  
  

  Back to Top

• First new class of COPD drug for 10 years
  
  08 Jul 2010
  Nycomed’s anti-inflammatory therapy Daxas (roflumilast) has received a marketing authorisation in the EU for patients with COPD associated with chronic bronchitis. Read More
  
  

  Back to Top

• EC approves new indication for Orencia
  
  08 Jul 2010
  Orencia (abatacept) has been approved in the EU as the first choice biologic to treat active rheumatoid arthritis (RA) after the failure of disease-modifying anti-rheumatic drugs (DMARDs). Read More
  
  

  Back to Top

• Pharma makes fewer ‘pay for delay’ deals
  
  07 Jul 2010
  The number of pharma patent settlements that could be regarded as suspicious under the EU’s antitrust rules has decreased in recent years. Read More
  
  

  Back to Top

• PCTs rely on pharma for staff training
  
  07 Jul 2010
  PCT’s have been warned not to rely too heavily on pharma companies to provide education for practice nurses. Read More
  
  

  Back to Top

• EMA advises switching from Fabrazyme
  
  07 Jul 2010
  The CHMP has advised that no new patients should be started on Fabrazyme (agalsidase beta) due to continued shortages of the drug. Read More
  
  

  Back to Top

• Herceptin not recommended in stomach cancer
  
  06 Jul 2010
  NICE has decided not to recommend Roche’s Herceptin (trastuzumab) for use in stomach cancer due to doubts over the extent to which it can extend life. Read More
  
  

  Back to Top

• EU approval for chewable Lipitor
  
  06 Jul 2010
  A new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older has been approved by the European Commission. Read More
  
  

  Back to Top

• Shire named Mediscience company of the year
  
  06 Jul 2010
  Global specialty biopharmaceutical company Shire was named Company of the Year at the European Mediscience Awards 2010. Read More
  
  

  Back to Top

• GSK launches new renal cancer drug
  
  05 Jul 2010
  A new first-line treatment for advanced renal cell carcinoma (RCC) has been launched in Europe following a conditional EMA approval. Read More
  
  

  Back to Top

News powered by Pharmaceutical Field (Pf)